Experience

Oncology Clinical Trial Experience

Our clinical team members and medical personnel have critical first-hand experience in the complex issues often associated with oncology clinical trials, which means that highly experienced resources will be working on your study.

Whether it’s a standard dose-escalation phase I trial or a complex rescue of a phase III trial, chances are that our team has handled it before.

Our Quality, Timeline and Budget Metrics

Since our inception, Medelis has achieved:

96% of projects on budget
91% of projects completed on time
Zero (0) critical findings noted in audits

Indications, sponsor types and geographic experience

Our team has managed phase I through phase IIIs in the US, Canada and Europe.
We offer extensive EDC experience including usage in those phase I trials that need to carefully balance costs and reporting speed.
We’ve worked with all different sponsor types: public and private, biotech and pharmaceutical, governmental, large and small, European and U.S.
We’ve handled most targets within oncology.

Trial Experience

Medelis has extensive experience in phase I through phase III oncology studies, across almost every indication, with most sponsor types: public and private, biotech and pharmaceutical, governmental, (U.S. and European).

Drug Therapies

Medelis has been managing drug therapy studies in oncology and opthalmology in phases I – III. We work directly with sponsors on the development of clinical strategy and with study execution in this for drug therapy studies.

Rescue Studies

Medelis has developed a rescue study procedure for its clients and in virtually every case, we’ve been able to reverse almost all problems, and regain most of the lost time with minimal additional expense to the client.